Elite Pharmaceuticals Inc (ELTP)
0.4999
-0.02
(-2.93%)
USD |
OTCM |
Nov 07, 16:00
Elite Pharmaceuticals Revenue (Annual): 56.63M for March 31, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
March 31, 2024 | 56.63M |
March 31, 2023 | 34.16M |
March 31, 2022 | 32.26M |
March 31, 2021 | 25.38M |
March 31, 2020 | 17.99M |
March 31, 2019 | 7.568M |
March 31, 2018 | 7.459M |
March 31, 2017 | 9.638M |
March 31, 2016 | 12.50M |
March 31, 2015 | 5.015M |
March 31, 2014 | 4.601M |
March 31, 2013 | 3.404M |
March 31, 2012 | 2.424M |
Date | Value |
---|---|
March 31, 2011 | 4.266M |
March 31, 2010 | 3.344M |
March 31, 2009 | 2.275M |
March 31, 2008 | 1.413M |
March 31, 2007 | 1.144M |
March 31, 2006 | 0.5507M |
March 31, 2005 | 0.3015M |
March 31, 2004 | 0.2582M |
March 31, 2003 | 0.6303M |
March 31, 2002 | 1.198M |
March 31, 2001 | 0.0952M |
March 31, 2000 | 0.0103M |
March 31, 1999 | 0.1504M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
17.99M
Minimum
2020
56.63M
Maximum
2024
33.28M
Average
32.26M
Median
2022
Revenue (Annual) Benchmarks
Biomarin Pharmaceutical Inc | 2.419B |
BioCardia Inc | 0.477M |
Zevra Therapeutics Inc | 27.46M |
Verrica Pharmaceuticals Inc | 5.124M |
Terns Pharmaceuticals Inc | -- |